Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Feeling abnormal, Injection site pain, Limb discomfort, Muscular weakness
Clinical narrative: felt a sharp "stick"; still felt like I had a deep bruise / thought" that the injection might have gone deep and hit bone.; tender if I put pressure on upper arm (like laying on it); uncomfortable if I put pressure on my upper arm (like laying on it); Pain at injection site; Muscle soreness/weakness which persists months after vaccination,some upper arm weakness in my left arm /  significant muscle weakness when lifting /  left arm feeling like it is about to collapse; First dose was 1 ml; Muscle soreness/muscle soreness that has dissipated / sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle soreness/weakness which persists months after vaccination,some upper arm weakness in my left arm /  significant muscle weakness when lifting /  left arm feeling like it is about to collapse), OVERDOSE (First dose was 1 ml), FEELING ABNORMAL (felt a sharp "stick"), CONTUSION (still felt like I had a deep bruise / thought" that the injection might have gone deep and hit bone.) and TENDERNESS (tender if I put pressure on upper arm (like laying on it)) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032m20a and 017b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DEXTROMETHORPHAN HYDROBROMIDE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL NIGHTTIME) from 16-Mar-2021 to 22-Mar-2021 for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter once. On 14-Apr-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced OVERDOSE (First dose was 1 ml) and MYALGIA (Muscle soreness/muscle soreness that has dissipated / sore arm). On 16-Mar-2021 at 3:00 PM, the patient experienced MUSCULAR WEAKNESS (Muscle soreness/weakness which persists months after vaccination,some upper arm weakness in my left arm /  significant muscle weakness when lifting /  left arm feeling like it is about to collapse) and INJECTION SITE PAIN (Pain at injection site). On an unknown date, the patient experienced FEELING ABNORMAL (felt a sharp "stick"), CONTUSION (still felt like I had a deep bruise / thought" that the injection might have gone deep and hit bone.), TENDERNESS (tender if I put pressure on upper arm (like laying on it)) and LIMB DISCOMFORT (uncomfortable if I put pressure on my upper arm (like laying on it)). On 16-Mar-2021, OVERDOSE (First dose was 1 ml) had resolved. On 21-Mar-2021, INJECTION SITE PAIN (Pain at injection site) had resolved with sequelae. On 21-Jul-2021, MUSCULAR WEAKNESS (Muscle soreness/weakness which persists months after vaccination,some upper arm weakness in my left arm /  significant muscle weakness when lifting /  left arm feeling like it is about to collapse) and MYALGIA (Muscle soreness/muscle soreness that has dissipated / sore arm) had not resolved. At the time of the report, FEELING ABNORMAL (felt a sharp "stick"), CONTUSION (still felt like I had a deep bruise / thought" that the injection might have gone deep and hit bone.), TENDERNESS (tender if I put pressure on upper arm (like laying on it)) and LIMB DISCOMFORT (uncomfortable if I put pressure on my upper arm (like laying on it)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow up: ethnic group, race, dose 2, con-meds, events were updated.